SCHEMBL7790102

SCHEMBL7790102

CCc1cc(OC2CCCC(Cc3cccc(C(F)(F)C(F)(F)F)c3)(NCC(O)C(F)(F)F)C2)ccc1Cl

nearest known ligand 0.49

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CETP P11597 11/20 0.49
HRH1 P35367 1/20 0.33
CCR3 P51677 1/20 0.33
KCNH2 Q12809 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7790147 0.89 CETP (0.49) CETP
SCHEMBL6567860 0.88 CETP (0.50) CETP
SCHEMBL5669268 0.86 CETP (0.40) CETP
SCHEMBL5669788 0.82 CETP (0.35) CETPHRH1CCR3KCNH2
SCHEMBL5670850 0.82 CETP (0.33) CETP
SCHEMBL5669750 0.82 CETP (0.32) CETP
SCHEMBL6274752 0.80 CETP (0.41) CETP
SCHEMBL5669307 0.79 CETP (0.35) CETP
SCHEMBL5669973 0.75 SMYD3 (0.36) CETP
SCHEMBL994912 0.75 CETP (0.60) CETPHRH1CCR3KCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity G.D. SEARLE & CO. (US) 2001-08-30 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20010018446-A1 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity CETP, DBI, MTTP CETP 1/4885HRH1 1972/4885CCR3 1946/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.